07 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/07/2976860/0/en/Adagene-Presents-Two-Posters-with-New-Insights-on-Increased-Therapeutic-Index-for-Masked-Anti-CTLA-4-SAFEbody-ADG126-Muzastotug-and-Data-Reinforcing-Clinical-Safety-and-Efficacy-fo.html
16 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/16/2810362/0/en/Adagene-Presents-Interim-Results-Reinforcing-Best-in-Class-Profile-of-Masked-anti-CTLA-4-SAFEbody-ADG126-muzastotug-in-Combination-with-Pembrolizumab-in-Metastatic-Microsatellite-s.html
04 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/04/2803770/0/en/Adagene-To-Present-Interim-Results-of-Masked-anti-CTLA-4-SAFEbody-ADG126-muzastotug-in-Combination-with-Pembrolizumab-in-MSS-CRC-at-ASCO-GI-Symposium.html
LOOKING FOR A SUPPLIER?